Diagnostics and prognostic evaluation in renal cell tumors: the German S3 guidelines recommendations - Takeaways - MDSpire

Diagnostics and prognostic evaluation in renal cell tumors: the German S3 guidelines recommendations

  • By

  • Kerstin Junker

  • Peter Hallscheidt

  • Heiko Wunderlich

  • Arndt Hartmann

  • March 16, 2022

  • 0 min

Share

  • 1

    The German S3 guidelines provide systematic recommendations for diagnosing and evaluating renal cell tumors based on extensive literature review.

  • 2

    Imaging techniques like CT and MRI are crucial for accurate diagnosis, staging, and treatment planning of renal cell carcinomas.

  • 3

    Core biopsy is recommended for histopathological evaluation of uncertain renal lesions, especially in candidates for active surveillance.

  • 4

    Histopathological classification of renal cell tumors follows the WHO and ISUP guidelines, incorporating new entities recognized in recent consensus.

  • 5

    The guidelines emphasize the need for molecular biomarkers to enhance diagnostic accuracy and individualize treatment for renal cell tumors.

Original Source(s)

Diagnostics and prognostic evaluation in renal cell tumors: the German S3 guidelines recommendations

  • by Kerstin Junker, Peter Hallscheidt, Heiko Wunderlich, Arndt Hartmann

  • March 16, 2022

Related Content

Digital Health in Pediatric Neurology: From Episodic to Continuous Care

Digital health has emerged as a transformative force in 21st-century medicine, reshaping the boundaries of healthcare delivery.

  • by

  • May 12, 2026

  • 4 min
Case Report: Bilateral Wilms tumor with TP53 mutation: a case-based review of clinical challenges

Combined ctDNA and serum PSA for dynamic monitoring of metastatic prostate cancer starting first-line treatment: a prospective national cohort study